Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Experimental and Therapeutic Medicine
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-0981 Online ISSN: 1792-1015
Journal Cover
July-2021 Volume 22 Issue 1

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
July-2021 Volume 22 Issue 1

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article Open Access

Morphological alterations of the pyramidal and stellate cells of the visual cortex in schizophrenia

  • Authors:
    • Ioannis Mavroudis
    • Foivos Petrides
    • Dimitrios Kazis
    • Symela Chatzikonstantinou
    • Eleni Karantali
    • Alin Ciobica
    • Alin-Constantin Iordache
    • Romeo Dobrin
    • Constantin Trus
    • Samuel Njau
    • Vasiliki Costa
    • Stavros Baloyannis
  • View Affiliations / Copyright

    Affiliations: Laboratory of Neuropathology and Electron Microscopy First Department of Neurology, Aristotle University of Thessaloniki, Thessaloniki 54634, Greece, Third Department of Neurology, Aristotle University of Thessaloniki, Thessaloniki 57010, Greece, Department of Biology, Faculty of Biology, Alexandru Ioan Cuza University, Iasi 700506, Romania, Faculty of Medicine, ‘Grigore T. Popa’, University of Medicine and Pharmacy, Iasi 700115, Romania, Department of Morphological and Functional Sciences, Faculty of Medicine, Dunarea de Jos University, Galati 050094, Romania, Department of Forensic Medicine and Toxicology, Aristotle University of Thessaloniki, Thessaloniki 54634, Greece
    Copyright: © Mavroudis et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Article Number: 669
    |
    Published online on: April 22, 2021
       https://doi.org/10.3892/etm.2021.10101
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Schizophrenia is a severe brain disorder characterized by certain types of delusion, hallucination and thought disorder. Studies have revealed impaired synaptic plasticity and reduced gamma‑aminobutyric acid levels of the visual cortex in patients with schizophrenia. While previous work established a critical role for interneurons and cortical connectivity in the generation of hallucinations, the present study set out to examine the morphology of pyramidal cells and interneurons from layers 3 and 4 in the primary visual cortex from schizophrenic brains and to identify any dendritic and spinal alterations in comparison to normal control brains. The morphological and morphometric changes of the pyramidal cells and the interneurons of the visual cortices of 10 brains obtained from patients with schizophrenia, in comparison to 10 age‑matched controls, were studied using the Golgi method and 3D neuronal reconstruction techniques. Analysis using the Golgi impregnation technique revealed a significant loss of distal dendritic segments, tortuous branches and varicosities and an overall restriction of the dendritic field in the brains of schizophrenic patients in both pyramidal cells and in aspiny interneurons. The present results may explain certain clinical phenomena associated with the visual cortex usually encountered in schizophrenia.

Introduction

Schizophrenia is a severe brain disorder characterized by certain types of delusion, hallucination and thought disorder (1,2). In addition to these aforementioned symptoms that may be associated with enhanced brain activity, schizophrenic patients develop additional symptoms of inhibition, including avolition, alogia and affective flattening (2). Macroscopically, schizophrenic brains exhibited enlargement of the ventricles and an overall reduction in the temporal volume, while microscopical examination of the brain revealed synaptic and spinal alterations, as well as gliosis, in various brain areas, including hippocampal formation and the prefrontal and the entorhinal cortices (3-9). Additional studies have revealed increasing neuronal packaging density, as well as decreased neuropil and smaller cell somata of the pyramidal neurons in layer 3 in different brain areas, including the primary and association auditory cortices, in schizophrenia (9-12). Dendritic spines perform a crucial role in regulating neuronal excitability while receiving the vast majority of excitatory synapses in the cortex (13,14). Deficits in spines are related to impairments in the working memory, attention, sensory-motor processing and sociability (15-17). Spine density has been reported to be significantly reduced in neurons of the auditory cortex (12) and the basilar dendrites of deep layer 3 pyramidal neurons (10), but did not differ for pyramidal neurons in the superficial layer 3 or layers 5 and 6 of area 46 (10,18). The spinal changes are thought to arise during development and are probably related to disturbances of the mechanisms underlying the formation and maintenance of spines.

Visual hallucinations are the second most common type of hallucinations in schizophrenia (2). Previous studies demonstrated a critical role for interneurons and cortical connectivity in the generation of hallucinations (19,20). At the same time, studies on the visual cortex of schizophrenic brains have revealed impaired synaptic plasticity and reduced gamma-aminobutyric acid (GABA) levels (21-23).

In the present study, the morphology of the pyramidal cells and interneurons in the visual cortex from brains of schizophrenic patients were examined. It was attempted to describe any possible dendritic and spinal alterations compared to normal control brains.

Patients and methods

Subjects

Brain samples were obtained from 10 neurologically normal individuals with no history of neurological or psychiatric illness, and 10 patients with schizophrenia, between January 2010 to December 2014 from the Department of Forensic Medicine and Toxicology, at the Aristotle University of Thessaloniki, Greece. All of the subjects were aged between 40 and 58 years (Schizophrenia: Mean age, 48.6±5.7 years; 6 males and 4 females; Controls: Mean age, 46.3±4.97 years; 7 males and 3 females) and died from heart attack. The average autolysis time for all subjects was 12±4 h. After their excision from the skull, all brains were immersed in 10% neutral buffered formalin for at least 25 days. All possible information on each subject regarding their previous physical and illness history was obtained from autopsy reports and medical records. The mean duration of the disease was 21±7 years and they had all been prescribed antipsychotic medication. Written informed consent regarding the use of the tissue for research purposes was obtained from the relatives of each of the deceased. The present study was performed according to the legislation of the Greek Democracy (v.2,472/1997, 2,819/2000, 2,915/2001, 3,235/2004 and 3,471/2006) and the Committee for Research Deontology Principles of the Aristotle University of Thessaloniki (24). The ethical approval number was 23/4/4521/2018. The brains were macroscopically and microscopically examined by an independent neuropathologist and did not exhibit any trauma, oedema or other pathology. Independent psychiatrists based at the Psychiatric Hospital of Thessaloniki, made the diagnosis of schizophrenia based on the criteria of the Diagnostic and Statistical Manual of Mental Disorders Text Revision 5. All of the patients exhibited visual hallucinations in their disease history.

Tissue selection and processing

A tissue block measuring 10x5x20 mm was excised from the primary visual cortex or V1 area (calcarine sulcus) (25) (Fig. 1A). The primary visual cortex may be easily recognized by a band of myelinated axons that run parallel to the surface (line of Gennari; Fig. 1B). The tissue blocks were coded to prevent experimental bias and were processed with the Golgi method and subjected to Nissl staining (26).

Figure 1

(A) The primary visual cortex is located in and around the calcarine fissure in the occipital lobe (arrow). Occipital lobe sagittal view demonstrating the calcarine fissure. (B) It may be easily recognized by a white band of myelinated axons that run parallel to the surface (line of Gennari; arrow).

Cell selection criteria

Two neuronal types were selected for the present study; the first one corresponds to the third cortical layer's pyramidal neurons and the second to the inhibitory aspiny stellate interneurons of the visual cortex. All neurons chosen for the study were uniformly stained, there was no precipitated debris around them and a good contrast between them and background were present (27).

Golgi method

For silver impregnation, the specimens were immediately immersed in a dilution of potassium dichromate (7 g of potassium dichromate and 20 ml of formaldehyde solution 37% in 300 ml of tap water) at room temperature. They remained in that solution for one week and were then immersed in an aqueous solution of 1% silver nitrate, where they remained for one more week at a temperature of 15˚C.

After fixation, the specimens were immersed in paraffin and cut into thick sections ~120 µm thick, as neuronal fields can be seen at their whole thickness at ~120 µm (25), using a Reichert slicing microtome. A total of 5 randomly selected sections were obtained, with a 480 µm distance between each sample. All of the specimens were examined with an Axiostar Plus bright field microscope (Zeiss AG).

Nissl staining

Adjacent sections were cut at a thickness of 20 µm and used for Nissl staining to evaluate the neuronal population and define the depth of cortical layers and measure the thickness of the cortex (25).

Neuronal tracing and dendritic quantification

For each one of the 20 brains, 50 pyramidal cells and 50 interneurons were selected. The neurons were then analyzed based on the method described in a previous study by our group (26).

Dendritic measures and Sholl analysis

For the morphometric estimation, soma size, total dendritic length, cell contraction, dendritic field asymmetry, the total number of dendritic segments and bifurcations, and the length and number of dendritic segments per order were measured. Furthermore, the tracings were quantitatively analyzed with Fiji software (version 2017; Fiji) and the Simple Neurite Tracer plugin based on Sholl's method of concentric spheres (28,29). Concentric spheres were drawn at intervals of 10 µm centred on the cell bodies and dendritic intersections within each sphere were counted (25).

Spine counts

The dendritic spine density was measured in 360 images, which were taken at a magnification of x1,000. Two different investigators (FP and SC) independently counted visible spines on three random segments of the dendritic tree of 20-30 µm in length, the first one being on a first-order dendrite, the second on a second-order dendrite and the third on a tertiary branch (30).

Statistical analysis

Statistical analysis was performed using Student's t-test based on 320 cells in R Studio (v. 4.04). To make sure that the autolysis time did not affect dendritic measurements, two-tailed Pearson product correlation analyses were performed between all dependent measures and autolysis time (31). P<0.05 was considered to indicate a statistically significant difference.

Results

Dendritic changes of pyramidal neurons

Analysis with the Golgi impregnation technique revealed a significant loss of distal dendritic segments, tortuous branches and varicosities and an overall restriction of the dendritic field in the schizophrenic brains compared to the normal brains (Fig. 2A and B).

Figure 2

Representative images of pyramidal neurons impregnated with the Golgi method, from (A) a schizophrenic brain and (B) a normal control (Golgi method; magnification, x100).

In the brains of schizophrenic subjects, the dendritic field's total length was significantly decreased as compared with that of normal subjects (Figs. 3A-D and 4A). A severe loss of distal dendritic branches (quaternary) (Fig. 4B), and a decrease in the number of terminal branches (Fig. 4C) and dendritic bifurcations were also noted (Fig. 4D).

Figure 3

Schematic representation based on neuronal tracings of (A) aspiny in normal controls, (B) aspiny in schizophrenic brains, (C) pyramidal neurons in normal controls and (D) pyramidal neurons in schizophrenic brains showing markedly decreased dendritic arborizations in each cell type in Schizophrenia.

Figure 4

Comparison of (A) total dendritic length (P=0.0002), (B) number of dendritic branches (P=0.0032), (C) number of terminals (P=0.00001) and (D) bifurcations (P=0.0001) of the pyramidal cells from NC and schizophrenic brains. Boxplots represent skewness and error bars indicate the standard deviation. NC, normal controls; Sch, schizophrenia group.

Compared to the normal controls, the branching ratio was reduced in the schizophrenic group, and the average branch length (Fig. 5A) and the maximum branching order were likewise affected (Fig. 5B). As presented in Fig. 6, Sholl analysis indicated a restriction of the dendritic field due to the loss of distal branches, although the proximal ones in the pyramidal cells remained intact (Fig. 6A). A small amount of degenerated pyramidal neurons was also noted in the schizophrenic brains, and none were identified in the control group (Fig. 7).

Figure 5

Comparison of (A) average branch length (P=0.00049) and (B) branch order (P=0.0001) of the pyramidal cells from NC and schizophrenic brains. Boxplots represent skewness and error bars indicate the standard deviation. NC, normal controls; Sch, schizophrenia group.

Figure 6

Sholl analysis of (A) the pyramidal cells and (B) interneurons of the visual cortex from NC and schizophrenic brains (bold line). Statistical significance was identified for distances >120 µm for pyramidal neurons and >100 µm for stellate neurons *P<0.05 vs. the NC group. NC, normal controls; Sch, schizophrenia group.

Figure 7

In schizophrenic brains, certain degenerated pyramidal neurons were noted (red arrows). No degenerated neurons were identified in the controls (Golgi method; magnification, x100).

Interneurons

Aspiny stellate interneurons of the visual cortex from the schizophrenic brains exhibited a significant decrease of the total dendritic length (Figs. 8A and B and 9A), severe loss of dendritic branches (Fig. 9B) and a substantial reduction of the number of terminal dendritic branches (Fig. 9C). The branching ratio was grossly reduced, and the average branch length and the maximum branch order were significantly affected (Fig. 10A and B). Sholl analysis of interneurons indicated extensive loss of distal dendritic branches and decline of the dendritic field density at a distance >100 µm from the cell soma (Fig. 6B). The number of bifurcations was markedly lower in schizophrenic brains compared with controls (Fig. 9D).

Figure 8

Representative examples of aspiny interneurons impregnated with the Golgi method from (A) normal controls and (B) schizophrenic brains (Golgi method; magnification, x100).

Figure 9

Comparison of (A) total dendritic length (P=0.0049), (B) number of branches (P=0.003), (C) numbers of terminals (P=0.00021) and (D) bifurcations (P=0.0001) of interneurons from NC and schizophrenic brains. Boxplots represent skewness and error bars indicate the standard deviation. NC, normal controls; Sch, schizophrenia group.

Figure 10

Comparison of (A) average branch length in µm (P=0.001) and (B) branch order (P=0.001) of interneurons from NC and schizophrenic brains. Boxplots represent skewness and error bars indicate the standard deviation. NC, normal controls; Sch, schizophrenia group.

Spinal changes

Pyramidal neurons exhibited a significant decrease in spinal density, affecting mainly the distal dendritic segments, while dystrophic and giant spines were also observed (Figs. 11 and 12).

Figure 11

Spinal density of the pyramidal neurons of the visual cortex from NC and schizophrenic brains (P=0.0034). Boxplots represent skewness and error bars indicate the standard deviation. NC, normal controls; Sch, schizophrenia group.

Figure 12

Representative examples of dendritic segments from (A) normal controls and (B-D) schizophrenic brains indicating (B) significant loss of dendritic spines, (C) patchy areas devoid of spines and (D) dystrophic spines (Golgi method; magnification, x1,000).

Cortical thickness

The thickness of the primary visual cortex measured in Nissl preparations was significantly different between the groups of the study (Schizophrenia, 1,956±105 µm; Controls, 2,124±96 µm; P=0.023; Fig. 13).

Figure 13

The depth of the primary visual cortex in patients with Sch and NCs. Boxplots represent 1st and 3rd quartiles, whiskers represent lower and higher values. Sch, Schizophrenia; NC, control.

Discussion

There remains a lack of consensus or set of quantified patient characteristics in regards to Schizophrenia and it has remained an enigma to neuropathologists (32). Accumulating evidence from macroscopic and microscopic pathology has been provided in the last 20 years. The main macroscopic findings include a decrease in brain weight (33-35), brain length (36) and volume of the cerebral hemispheres (37). An additional enlargement of the lateral ventricles (36,37), changes to limbic structures (38), reduced size of temporal lobe structures (39-41), decreased thalamic volume (34,42) and enlarged basal ganglia (43) have also been described. Certain findings regarding synaptic and spinal pathology, cell orientation, neuronal density, neuronal size, protein expression and neurotransmitter deficits have also been consistently reported by numerous studies (6).

The majority of existing studies are focused on hippocampal formation, the temporal lobe, prefrontal cortex and basal ganglia. To the best of our knowledge, no previous study has reported on the morphological changes of the pyramidal and stellate neurons of the occipital lobe. In 1998, Garey et al (44) reported decreased spinal density on the pyramidal cells of lamina III from Brodmann areas 11 and 38 observed on Golgi staining, and in the same year, Woo et al (45) indicated a selective decrease of terminal branches in brodmann areas 9 and 46 chandelier neurons.

In 1996, Roberts et al (46) revealed changes of the dendritic spines at the striatum, and in the same year, Uranova et al (47) described certain changes in the postsynaptic density of axo-spinous synapses.

In addition, Dorph-Petersen et al (22) reported significantly decreased neuronal volume with no significant reduction of the neuronal density in the primary visual cortex of schizophrenic brains. These results were confirmed by neuroimaging studies using voxel-based morphometry, which reported a significant reduction in the occipital lobe's overall volume with a decrease in grey matter in schizophrenic patients (48-52).

In the present study, no significant changes in the neuronal density of the primary visual cortex were obtained, but the overall thickness of the primary visual cortex was substantially decreased in schizophrenic brains, corroborating the findings of the earlier study by Dorph-Petersen et al (22). Golgi silver staining and 3D reconstruction of neurons revealed several morphological changes on both cortical aspiny interneurons and pyramidal cells. The total neuronal volume was decreased in both populations. The aspiny interneurons exhibited a severe restriction of their dendritic field areas, along with a loss of distal and terminal dendritic branches. Pyramidal neurons from lamina III similarly exhibited a significant loss of terminal branches and substantially lower dendritic spines, mainly on the distal branches.

Regarding the clinical significance of the present results, visual hallucinations are amongst the most common symptoms associated with increased brain activity in patients with schizophrenia (48). They have been correlated to GABA deficits and functional impairment of cortical interneurons, as well as a disturbance of cortico-thalamic or intracortical connections (19). Furthermore, studies have revealed certain functional deficits of the visual cortex in schizophrenic patients, including early-stage visual processing, contrast sensitivity abnormalities, surround suppression and motor processing disturbance (53,54). Lamina III pyramidal neurons contribute to reception, elaboration and transmission of the visual information to other cortical areas, while the aspiny interneurons provide inhibitory control and modulate the synchronized oscillations (55). Both neuronal populations are critical for the integrity of the cortico-thalamic and intracortical circuits. The loss of dendrites and dendritic spines of both pyramidal cells and interneurons leads to a substantial decrease of the synaptic contacts and a significant impairment of the pyramidal-interneuronal connectivity, as well as of the connections of the cells of the visual cortex with the neurons of other cortical and subcortical areas, which may be implicated in the modulation of the visual information (30,55). Although other cortical areas beyond the primary visual cortex are related to the production of visual hallucinations, the interruption of connectivity of the primary visual cortex with secondary visual, temporal and parietal areas may have a crucial role in the pathophysiology of visual hallucinations and other functional deficits of the visual cortex in schizophrenia.

To the best of our knowledge, the present study was the first to describe the morphological alterations in pyramidal and spinal stellate neurons on the primary visual cortex in patients with schizophrenia. The results may provide novel insights into the brain changes exhibited by patients with schizophrenia. It may be concluded that the present observations may be related to certain clinical phenomena associated with the visual cortex usually encountered in schizophrenia.

Acknowledgements

Not applicable.

Funding

Funding: No funding was received.

Availability of data and materials

The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.

Authors' contributions

IM prepared the manuscript and supervised the data collection and analysis. FP, SC, EK and DK collected and analyzed the data, and prepared the specimens. AC, ACI, RD and CT prepared the manuscript and analyzed the data. SN, VC and SB made substantial contributions to conception and design, acquisition of data and analysis and interpretation of data. IM and SB confirm the authenticity of all the raw data. All authors have read and approved the final manuscript.

Ethics approval and consent to participate

The present study was performed according to the legislation of the Greek Democracy (v.2,472/1997, 2,819/2000, 2,915/2001, 3,235/2004 and 3,471/2006) and the Committee for Research Deontology Principles of the Aristotle University of Thessaloniki (24) (approval no. 23/4/4521/2018). Written informed consent was obtained from relatives.

Patient consent for publication

For each of the patients and controls, and written informed consent was obtained from their relatives and power of attorneys regarding the publication of data and associated images.

Competing interests

The authors declare that they have no competing interests.

References

1 

McKenna K, Gordon C and Rapoport J: Childhood-onset schizophrenia: Timely neurobiological research. J Am Acad Child Adolesc Psychiatry. 33:771–781. 1994.PubMed/NCBI View Article : Google Scholar

2 

Andreasen N: Symptoms, signs, and diagnosis of schizophrenia. Lancet. 346:477–481. 1995.PubMed/NCBI View Article : Google Scholar

3 

Flaum M, Arndt S and Andreasen NC: The role of gender in studies of ventricle enlargement in schizophrenia: A predominantly male effect. Am J Psychiatry. 147:1327–1332. 1990.PubMed/NCBI View Article : Google Scholar

4 

Jellinger K: Neuromorphological Background of Pathochemical Studies in Major Psychoses. 1st Edition, Springer, Berlin, pp1-23, 1985.

5 

Johnstone EC, Bruton CJ, Crow TJ, Frith CD and Owens DG: Clinical correlates of postmortem brain changes in schizophrenia: Decreased brain weight and length correlate with indices of early impairment. J Neurol Neurosurg Psychiatry. 57:474–479. 1994.PubMed/NCBI View Article : Google Scholar

6 

Harrison PJ: The neuropathology of schizophrenia. A critical review of the data and their interpretation. Brain. 122:593–624. 1999.PubMed/NCBI View Article : Google Scholar

7 

Haug JO: Pneumoencephalographic evidence of brain atrophy in acute and chronic schizophrenic patients. Acta Psychiatr Scand. 66:374–383. 1982.PubMed/NCBI View Article : Google Scholar

8 

Porter RH, Eastwood SL and Harrison PJ: Distribution of kainite receptor subunit mRNAs in human hippocampus, neocortex and cerebellum, and bilateral reduction of hippocampal GluR6 and KA2 transcripts in schizophrenia. Brain Res. 751:217–231. 1997.PubMed/NCBI View Article : Google Scholar

9 

Rajkowska G, Selemon LD and Goldman-Rakic PS: Neuronal and glial somal size in the prefrontal cortex: A postmortem morphometric study of schizophrenia and Huntington disease. Arch Gen Psychiatry. 55:215–224. 1998.PubMed/NCBI View Article : Google Scholar

10 

Glantz LA and Lewis DA: Decreased dendritic spine density on prefrontal cortical pyramidal neurons in schizophrenia. Arch Gen Psychiatry. 57:65–73. 2000.PubMed/NCBI View Article : Google Scholar

11 

Pierri JN, Volk CL, Auh S, Sampson A and Lewis DA: Decreased somal size of deep layer 3 pyramidal neurons in the prefrontal cortex of subjects with schizophrenia. Arch Gen Psychiatry. 58:466–473. 2001.PubMed/NCBI View Article : Google Scholar

12 

Sweet RA, Pierri JN, Auh S, Sampson AR and Lewis DA: Reduced pyramidal cell somal volume in auditory association cortex of subjects with schizophrenia. Neuropsychopharmacology. 28:599–609. 2003.PubMed/NCBI View Article : Google Scholar

13 

DeFelipe J and Fariñas I: The pyramidal neuron of the cerebral cortex: Morphological and chemical characteristics of the synaptic inputs. Prog Neurobiol. 39:563–607. 1992.PubMed/NCBI View Article : Google Scholar

14 

Wilson CJ: GABAergic inhibition in the neostriatum. Prog Brain Res. 160:91–110. 2007.PubMed/NCBI View Article : Google Scholar

15 

Liston C, Miller MM, Goldwater DS, Radley JJ, Rocher AB, Hof PR, Morrison JH and McEwen BS: Stress-induced alterations in prefrontal cortical dendritic morphology predict selective impairments in perceptual attentional set-shifting. J Neurosci. 26:7870–7874. 2006.PubMed/NCBI View Article : Google Scholar

16 

Cahill ME, Xie Z, Day M, Photowala H, Barbolina MV, Miller CA, Weiss C, Radulovic J, Sweatt JD, Disterhoft JF, et al: Kalirin regulates cortical spine morphogenesis and disease-related behavioral phenotypes. Proc Natl Acad Sci USA. 106:13058–13063. 2009.PubMed/NCBI View Article : Google Scholar

17 

Brennaman LH, Kochlamazashvili G, Stoenica L, Nonneman RJ, Moy SS, Schachner M, Dityatev A and Maness PF: Transgenic mice overexpressing the extracellular domain of NCAM are impaired in working memory and cortical plasticity. Neurobiol Dis. 43:372–378. 2011.PubMed/NCBI View Article : Google Scholar

18 

Kolluri N, Sun Z, Sampson AR and Lewis DA: Lamina-specific reductions in dendritic spine density in the prefrontal cortex of subjects with schizophrenia. Am J Psychiatry. 162:1200–1202. 2005.PubMed/NCBI View Article : Google Scholar

19 

Boksa P: On the neurobiology of hallucinations. J Psychiatry Neurosci. 34:260–262. 2009.PubMed/NCBI

20 

de la Iglesia-Vaya M, Escartí MJ, Molina-Mateo J, Martí-Bonmatí L, Gadea M, Castellanos FX, Aguilar García-Iturrospe EJ, Robles M, Biswal BB and Sanjuan J: Abnormal synchrony and effective connectivity in patients with schizophrenia and auditory hallucinations. Neuroimage Clin. 6:171–179. 2014.PubMed/NCBI View Article : Google Scholar

21 

Cavus I, Reinhart RM, Roach BJ, Gueorguieva R, Teyler TJ, Clapp WC, Ford JM, Krystal JH and Mathalon DH: Impaired visual cortical plasticity in schizophrenia. Biol Psychiatry. 71:512–520. 2012.PubMed/NCBI View Article : Google Scholar

22 

Dorph-Petersen KA, Pierri JN, Wu Q, Sampson AR and Lewis DA: Primary visual cortex volume and total neuron number are reduced in schizophrenia. J Comp Neurol. 501:290–301. 2007.PubMed/NCBI View Article : Google Scholar

23 

Yoon JH, Maddock RJ, Rokem A, Silver MA, Minzenberg MJ, Ragland JD and Carter CS: GABA concentration is reduced in visual cortex in schizophrenia and correlates with orientation-specific surround suppression. J Neurosci. 30:3777–3781. 2010.PubMed/NCBI View Article : Google Scholar

24 

Research Committee. Research Deontology Principles. 2nd edition, Aristotle University of Thessaloniki, Thessaloniki, pp22-25, 2010.

25 

Mavroudis IA, Fotiou DF, Manani MG, Njaou SN, Frangou D, Costa VG and Baloyannis SJ: Dendritic pathology and spinal loss in the visual cortex in Alzheimer's disease a Golgi study in pathology. Int J Neurosci. 121:347–354. 2011.PubMed/NCBI View Article : Google Scholar

26 

Mavroudis IA, Petrides F, Manani M, Chatzinikolaou F, Ciobica AS, Padurariu M, Kazis D, Njau SN, Costa VG and Baloyannis SJ: Purkinje cells pathology in schizophrenia. A morphometric approach. Rom J Morphol Embryol. 58:419–424. 2017.PubMed/NCBI

27 

Jacobs B, Driscoll L and Schall M: Life-span dendritic and spine changes in areas 10 and 18 of human cortex: A quantitative Golgi study. J Comp Neurol. 386:661–680. 1997.PubMed/NCBI

28 

Johannes S, Arganda-Carreras I, Frise E, Kaynig V, Longair M, Pietzsch T, Preibisch S, Rueden C, Saalfeld S, Schmid B, et al: Fiji: An open-source platform for biological-image analysis. Nat Methods. 9:676–682. 2012.PubMed/NCBI View Article : Google Scholar

29 

Sholl DA: The organization of the visual cortex in the cat. J Physiol. 124:23–24. 1954.PubMed/NCBI

30 

Anderson K, Bones B, Robinson B, Hass C, Lee H, Ford K, Roberts TA and Jacobs B: The morphology of supragranular pyramidal neurons in the human insular cortex: A quantitative Golgi study. Cerebral Cortex. 19:2131–2144. 2009.PubMed/NCBI View Article : Google Scholar

31 

Plum F: Prospects for research on schizophrenia. 3. Neurophysiology. Neuropathological findings. Neurosci Res Program Bull. 10:384–388. 1972.PubMed/NCBI

32 

Brown R, Colter N, Corsellis JA, Crow TJ, Frith CD, Jagoe R, Johnstone EC and Marsh L: Postmortem evidence of structural brain changes in schizophrenia. Differences in brain weight, temporal horn area, and parahippocampal gyrus compared with affective disorder. Arch Gen Psychiatry. 43:36–42. 1986.PubMed/NCBI View Article : Google Scholar

33 

Pakkenberg B: The volume of the mediodorsal thalamic nucleus in treated and untreated schizophrenics. Schizophr Res. 7:95–100. 1992.PubMed/NCBI View Article : Google Scholar

34 

Bruton CJ, Crow TJ, Frith CD, Johnstone EC, Owens DG and Roberts GW: Schizophrenia and the brain: A prospective cliniconeuropathological study. Psycholo Med. 20:285–304. 1990.PubMed/NCBI View Article : Google Scholar

35 

Crow TJ, Ball J, Bloom SR, Brown R, Bruton CJ, Colter N, Frith CD, Johnstone EC, Owens DG and Roberts GW: Schizophrenia as an anomaly of development of cerebral asymmetry. Arch Gen Psychiatry. 46:1145–1150. 1989.PubMed/NCBI View Article : Google Scholar

36 

Pakkenberg B: Post-mortem study of chronic schizophrenic brains. Br J Psychiatry. 151:744–752. 1987.PubMed/NCBI View Article : Google Scholar

37 

Bogerts B, Falkai P, Haupts M, Greve B, Ernst S, Tapernon-Franz U and Heinzmann U: Post-mortem volume measurements of limbic system and basal ganglia structures in chronic schizophrenics. Initial results from a new brain collection. Schizophr Res. 3:295–301. 1990.PubMed/NCBI View Article : Google Scholar

38 

Falkai P, Bogerts B and Rozumek M: Limbic pathology in schizophrenia: The entorhinal region-a morphometric study. Biol Psychiatry. 24:515–521. 1998.PubMed/NCBI View Article : Google Scholar

39 

Falkai P and Bogerts B: Cell loss in the hippocampus of schizophrenics. Eur Arch Psychiatry Neurol Sci. 236:154–161. 1986.PubMed/NCBI View Article : Google Scholar

40 

Altshuler LL, Casanova MF, Goldberg TE and Kleinman JE: The hippocampus and parahippocampus in schizophrenia, suicide, and control brains. Arch Gen Psychiatry. 47:1029–1034. 1990.PubMed/NCBI View Article : Google Scholar

41 

Vogeley K, Hobson T, Schneider-Axmann T, Honer WG, Bogerts B and Falkai P: Compartmental volumetry of the superior temporal gyrus reveals sex differences in schizophrenia-a post-mortem study. Schizophr Res. 31:83–87. 1998.PubMed/NCBI View Article : Google Scholar

42 

Danos P, Baumann B, Bernstein HG, Franz M, Stauch R, Northoff G, Krell D, Falkai P and Bogerts B: Schizophrenia and anteroventral thalamic nucleus: Selective decrease of parvalbumin-immunoreactive thalamocortical projection neurons. Psychiatry Res. 82:1–10. 1989.PubMed/NCBI View Article : Google Scholar

43 

Heckers S, Heinsen H and Heinsen YC: Limbic structures and lateral ventricle in schizophrenia: A quantitative post-mortem study. Arch Gen Psychiatry. 47:1016–1022. 1991.PubMed/NCBI View Article : Google Scholar

44 

Garey LJ, Ong WY, Patel TS, Kanani M, Davis A, Mortimer AM, Barnes TR and Hirsch S: Reduced dendritic spine density on cerebral cortical pyramidal neurons in schizophrenia. J Neurol Neurosurg Psychiatry. 65:446–453. 1998.PubMed/NCBI View Article : Google Scholar

45 

Woo TU, Whitehead RE, Melchitzky DS and Lewis DA: A subclass of prefrontal gamma- aminobutyric acid axon terminals are selectively altered in schizophrenia. Proc Natl Acad Sci USA. 95:5341–5346. 1998.PubMed/NCBI View Article : Google Scholar

46 

Roberts RC, Conley R, Kung L, Peretti FJ and Chute DJ: Reduced striatal spine size in schizophrenia: A post-mortem ultrastructural study. Neuroreport. 7:1214–1218. 1996.PubMed/NCBI View Article : Google Scholar

47 

Uranova NA, Casanova MF, DeVaughn NM, Orlovskaya DD and Denisov DV: Ultrastructural alterations of synaptic contacts and astrocytes in postmortem caudate nucleus of schizophrenic patients (letter). Schizophr Res. 22:81–83. 1996.PubMed/NCBI View Article : Google Scholar

48 

Andreasen NC, Flashman L, Flaum M, Arndt S, Swayze V and O'Leary DS: Regional brain abnormalities in schizophrenia measured with magnetic resonance imaging. JAMA. 272:1763–1769. 1994.PubMed/NCBI

49 

Bilder RM, Wu H, Bogerts B, Ashtari M, Robinson D and Woerner M: Cerebral volume asymmetries in schizophrenia and mood disorders: A quantitative magnetic resonance imaging study. Int J Psychophysiol. 34:197–205. 1999.PubMed/NCBI View Article : Google Scholar

50 

Bilder RM, Wu H, Bogerts B, Degreef G, Ashtari M and Alvir JM: Absence of regional hemispheric volume asymmetries in first-episode schizophrenia. Am J Psychiatry. 151:1437–1447. 1994.PubMed/NCBI View Article : Google Scholar

51 

Goldstein JM, Goodman JM, Seidman LJ, Kennedy DN, Makris N and Lee H: Cortical abnormalities in schizophrenia identified by structural magnetic resonance imaging. Arch Gen Psychiatry. 56:537–547. 1999.PubMed/NCBI View Article : Google Scholar

52 

Zipursky RB, Lim KO, Sullivan EV, Brown BW and Pfefferbaum A: Widespread cerebral gray matter volume deficits in schizophrenia. Arch Gen Psychiatry. 49:195–205. 1992.PubMed/NCBI View Article : Google Scholar

53 

Butler P, Silverstein S and Dakin S: Visual perception and its impairment in schizophrenia. Biol Psychiatry. 64:40–47. 2008.PubMed/NCBI View Article : Google Scholar

54 

Slaghuis W: Contrast sensitivity for stationary and drifting spatial frequency gratings in positive and negative-symptom schizophrenia. J Abnorm Psychol. 107:49–62. 1998.PubMed/NCBI View Article : Google Scholar

55 

Jones KS, Corbin JG and Huntsman MM: Neonatal NMDA receptor blockade disrupts spike timing and glutamatergic synapses in fast spiking interneurons in a NMDA receptor hypofunction model of schizophrenia. PLoS One. 9(e109303)2014.PubMed/NCBI View Article : Google Scholar

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Mavroudis I, Petrides F, Kazis D, Chatzikonstantinou S, Karantali E, Ciobica A, Iordache A, Dobrin R, Trus C, Njau S, Njau S, et al: Morphological alterations of the pyramidal and stellate cells of the visual cortex in schizophrenia. Exp Ther Med 22: 669, 2021.
APA
Mavroudis, I., Petrides, F., Kazis, D., Chatzikonstantinou, S., Karantali, E., Ciobica, A. ... Baloyannis, S. (2021). Morphological alterations of the pyramidal and stellate cells of the visual cortex in schizophrenia. Experimental and Therapeutic Medicine, 22, 669. https://doi.org/10.3892/etm.2021.10101
MLA
Mavroudis, I., Petrides, F., Kazis, D., Chatzikonstantinou, S., Karantali, E., Ciobica, A., Iordache, A., Dobrin, R., Trus, C., Njau, S., Costa, V., Baloyannis, S."Morphological alterations of the pyramidal and stellate cells of the visual cortex in schizophrenia". Experimental and Therapeutic Medicine 22.1 (2021): 669.
Chicago
Mavroudis, I., Petrides, F., Kazis, D., Chatzikonstantinou, S., Karantali, E., Ciobica, A., Iordache, A., Dobrin, R., Trus, C., Njau, S., Costa, V., Baloyannis, S."Morphological alterations of the pyramidal and stellate cells of the visual cortex in schizophrenia". Experimental and Therapeutic Medicine 22, no. 1 (2021): 669. https://doi.org/10.3892/etm.2021.10101
Copy and paste a formatted citation
x
Spandidos Publications style
Mavroudis I, Petrides F, Kazis D, Chatzikonstantinou S, Karantali E, Ciobica A, Iordache A, Dobrin R, Trus C, Njau S, Njau S, et al: Morphological alterations of the pyramidal and stellate cells of the visual cortex in schizophrenia. Exp Ther Med 22: 669, 2021.
APA
Mavroudis, I., Petrides, F., Kazis, D., Chatzikonstantinou, S., Karantali, E., Ciobica, A. ... Baloyannis, S. (2021). Morphological alterations of the pyramidal and stellate cells of the visual cortex in schizophrenia. Experimental and Therapeutic Medicine, 22, 669. https://doi.org/10.3892/etm.2021.10101
MLA
Mavroudis, I., Petrides, F., Kazis, D., Chatzikonstantinou, S., Karantali, E., Ciobica, A., Iordache, A., Dobrin, R., Trus, C., Njau, S., Costa, V., Baloyannis, S."Morphological alterations of the pyramidal and stellate cells of the visual cortex in schizophrenia". Experimental and Therapeutic Medicine 22.1 (2021): 669.
Chicago
Mavroudis, I., Petrides, F., Kazis, D., Chatzikonstantinou, S., Karantali, E., Ciobica, A., Iordache, A., Dobrin, R., Trus, C., Njau, S., Costa, V., Baloyannis, S."Morphological alterations of the pyramidal and stellate cells of the visual cortex in schizophrenia". Experimental and Therapeutic Medicine 22, no. 1 (2021): 669. https://doi.org/10.3892/etm.2021.10101
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team